Several clones of Chinese hamster ovary cells resistant to the cytotoxicity of the phytohemagglutinin from Phaseolus vulgaris show decreased binding o 125I-labeled phytohemagglutinin and contain decreased levels of a UDP-N-acetylglucosamine-glycoprotein N-acetylglucosaminyltransferase (EC 2.4.1.51; UDP-2-acetamido-2-deoxy-D-glucose:glycoprotein 2-acetamido-2-deoxy-D-glucosyltransferase) activity when compared to wild-type cells. The decrease in transferase activity varies from 45% to 96%, depending on the exogenous acceptor used in the enzyme assay. No differences between lectin-resistant and wild-type cells were noted for several other glycosyltransferases. The absence of a particular N-acetylglucosaminyltransferase in the lectin-resistant cells apparently results in defective glycosylation of lectin-binding glycoproteins on the cell surface. A phytohemagglutinin-resistant clone which shows decreased binding of llsIlabeled phytohemagglutinin but does not exhibit the enzyme deficiency has also been isolated.
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Purified plant lectins exert numerous biological effects following their specific interaction with the carbohydrate moieties of glycoproteins at the cell surface (1, 2) . Many lectins are cytotoxic for cultured cells and have been used to select lectin-resistant cell lines (3) (4) (5) (6) (7) (8) . In our laboratory Chinese hamster ovary (CHO) cells resistant to the cytotoxicity of phytohemagglutinin from Phaseolus vulgaris (PHA) have been isolated and shown to behave as authentic somatic cell mutants possessing stable alterations at the cell membrane (9) . Several independently-selected PHA-resistant (PhaR) clones survive concentrations of PHA 60-to 100-fold the selective dose, bind markedly less '25I-labeled PHA at the cell membrane than wild-type cells, and exhibit a 4-to 5-fold increase in sensitivity compared with wild type to the cytotoxicity of concanavalin A (Con A) (9) . PhaR clones with these properties have recently been found to possess few terminal and penultimate galactose residues at the cell surface (10) . The PhaR phenotype behaves recessively in hybrids formed between PhaR and wild-type CHO clones (9) . A molecular basis for the PhaR phenotype consistent with these properties might be the absence of an N-acetyl-D-glucosaminyltransferase (GlcNAc-T) which attaches d3-linked GlcNAc to amannosyl termini of growing membrane-bound glycoproAbbreviations: PHA, phytohemagglutinin from Phaseolus vulgaris; Con A, concanavalin A; WGA, wheat germ agglutinin; RIC, toxin from Ricinus communis; LCA, agglutinin from Lens culinaris; GlcNAt-T, N-acetylglucosaminyltransferase; AGP(-SA), sialidasetreated al-acid glycoprotein; AGP(-SA,Gal), sialidase-, f-galactosidase-treated al-acid glycoprotein; AGP(-SA,Gal,GlcNAc), sialidase-, f3-galactosidase-, jS-N-acetylglucosaminidase-treated a,-acid glycoprotein; IgG(-SA,Gal,GlcNAc) glycopeptide, fl-galactosidase-, f3-Nacetyl-glucosaminidase-treated glycopeptide from sialic acid-deficient immunoglobulin G; CHO, Chinese hamster ovary. teins destined to become binding sites for PHA (11, 12) . Evidence for such an hypothesis is presented in this paper; a preliminary report has appeared (13) . (14) . ; nonradioactive UDP-galactose and UDP-GlcNAc were purchased from Sigma, whereas low specific activity CMP-N-acetylneuraminic acid (15, 16) and GDP-L-fucose (17) were synthesized in this laboratory. Human al-acid glycoprotein was prepared and sequentially degraded with glycosidases as described (18) (19) (20) (21) . Sialidase (22) , partially purified 13-galactosidase (20, 23) , and /3-N-acetylglucosaminidase (fraction DE GM2, ref. 23) were prepared from Cl. perfringens; the fl-galactosidase preparation contained a small amount of f3-N-acetylglucosaminidase activity (20) and the f3-N-acetylglucosaminidase preparation contained appreciable amounts of 13-galactosidase but was free of activities capable of hydrolyzing p-nitrophenyl-a-N-acetyl-D-glucosaminide, p-nitrophenyl-fl-N-acetyl-D-galactosaminide, and p-nitrophenyl-a-N-acetyl-D-galactosaminide. Mr. David Williams of this laboratory purified a glycopeptide from Pronase-digested sialidase-, ,B-galactosidase-, ,3-N-acetylglucosaminidase-treated al-acid glycoprotein [AGP(-SA,Gal,GlcNAc)] by chromatography on Sephadex G-25, Bio-Gel P-10, and Dowex-5OX2 (pyridinium); this glycopeptide was shown to have terminal a-mannosyl residues by demonstrating release of mannose on treatment with amannosidase from jack bean meal (Boehringer). An immunoglobulin G glycopeptide (24) that had been treated with 13-galactosidase and 13-N-acetylglucosaminidase to expose terminal a-mannosyl residues was the gift of Dr. Stuart Kornfeld. RNase B from bovine pancreas was purchased from Worthington. All other chemicals were obtained commercially. 3323 Cell Culture and Cell Lines. The selection and genetic characterization of PhaR CHO cells has been described in detail (9) . In most of the experiments reported here, comparisons are made between a parental wild-type CHO clone that is auxotrophic for proline (Pro-5) and a previously undescribed PhaR clone (Pro-PhaR1_1) selected in PHA in a single step from the wild-type line. The clone Pro-5PhaR12-2 was selected in PHA by Mr. Steven Rothstein from Pro-5 cells. Other cell lines used here are auxotrophic for glycine, adenosine, and thymidine and reverted for the proline marker (Gat-Pro+) and have been described (9) . This parental (wild-type) line is designated Gat-Pro+2, while the independently selected PhaR clones are referred to as GatPro+2PhaRl and Gat-Pro+lPhaRl, and a clone of the latter is Gat-Pro+1PhaRj-j. Cells were routinely grown in suspension at 370 in complete a medium (25) containing 10% fetal calf serum.
MATERIALS AND METHODS
Determination of Lectin Resistance. The abilities of wild-type and PhaR CHO cells to survive cytotoxic levels of different lectins were compared by determining the dose of lectin (,gg/ml) that reduced the relative plating efficiency (9) of the cells to 10% (D1o). Lectin resistance was sometimes determined semiquantitatively by comparing the ability of 2000 cells to form a monolayer at different lectin concentrations in the wells of a Microtest II tray (Falcon Plastics no. 3040). In these cases, a lower limit of the Djo value is given.
Binding of Iodinated Lectins. PHA, WGA, LCA, and Con A were iodinated with 125I using lactoperoxidase and hydrogen peroxide (9) . Each labeled lectin preparation was 80-90% precipitable by cold 10% (w/v) trichloroacetic acid. Washed cells (5 X 105) were incubated for 1 hr at room temperature with '25I-labeled lectin (about 2-4 ,g containing about 100,000 cpm) in 0.2 ml of phosphate-buffered saline containing Ca++ and Mg++ and 1% bovine serum albumin. Unbound 125I-labeled lectin was removed by centrifugation of the reaction mixture through 2.5% or 5% bovine serum albumin (9) . Cell-bound radioactivity was determined in a Nuclear Chicago Autogammna Counter. The binding to cells of each '25I-labeled lectin was inhibited about 90% by the presence of a 500-to 1000-fold excess of unlabeled lectin in the incubation mixture.
Preparation of Cell Extracts. Cells in logarithmic growth phase were harvested at a density of 4 to 8 X 105 cells per ml and washed three times with cold saline (about 6 ml per 107 cells). The cell concentration was determined using a Particle Data Electrozone/Celloscope cell counter, and aliquots containing the required number of washed cells were centrifuged at 1000 rpm for 10 min in a MSE Mistral 6 L centrifuge. For detergent extraction, 0.025 ml of saline and 0.05 ml of 5% (v/v) Triton X-100 were added per 107 cells to a final volume of 0.10 ml. The cells were mixed gently at room temperature until lysis had occurred; this was shown by phase contrast microscopy to take approximately 30 sec. After cooling to 40, undisrupted nuclei and whole cells were removed by centrifugation at 3000 rpm for 1 min as above and the supernatant was used in the transferase assays. The protein concentrations of wild-type and PhaR Triton X-100 cell extracts were usually between 10 and 14 mg/ml. No change in the released enzyme activity was observed if the incubation with Triton X-100 was prolonged to 3 hr at 40. For mannosyltransferase assays, washed cells were suspended in 0.075 ml of saline per 107 cells and disrupted by freezing and thawing three times; a supernatant was obtained by centrifugation as above and used in the transferase assays. The protein concentrations of these extracts were 6-8 mg/ ml.
Glycosyltransferase Assays. The incubation mixtures for the various transferase assays all contained 0.05-0.14 mg of enzyme protein in addition to the following: (i) Sialyltransferase (EC 2.4.99.1): AGP(-SA), 1 mg; piperazine-N,N'-bis(2-ethanesulfonate) buffer, pH 7.3, 2.5 Mmols; CMP-N-acetyl-MnCl2, 0.5 ,umol; UDP-N-acetyl-[14C]glucosamine, 3.5 X 106 cpm/,gmol, 0.027 IAmol; final volume, 0.04 ml. Incubations were at 370 for 1 hr. The mannosyltransferase incubation was terminated by addition of 0.05 ml of ice-cold 10% trichloroacetic acid/2% phosphotungstic acid; the precipitate was collected on a glass fiber filter and washed three times with 10 ml of 5% trichloroacetic acid/1% phosphotungstic acid and once with 25 ml of chloroform/methanol/water (1:1:0.3). The filter was dried and counted in a Nuclear Chicago liquid scintillation spectrometer. All other incubations were terminated by addition of 0.010 ml of 2% sodium tetraborate/0.25 M EDTA followed by high voltage electrophoresis in 1% sodium tetraborate (17) (18) (19) (20) (21) ; the fucosyl-and N-acetylgiucosaminyltransferase incubations were then subjected to descending paper chromatography with 80% ethanol. The origins of the papers were dried, and radioactivity was determined by previously described liquid scintillation techniques (17) (18) (19) (20) (21) .
All incubations were carried out at two protein concentrations and, except for mannosyltransferase, both in the absence and presence of exogenous acceptors. The incorporations in the absence of acceptor were subtracted from exogenous acceptor values in the calculation of all enzyme velocities. Rate of product formation was proportional to enzyme protein for all transferases except the mannosyltransferase; data for the latter enzyme must therefore be considered preliminary.
Product Identification. The standard GlcNAc-T incubations were scaled up 5-to 10-fold and incubated at 370 for 3 hr. The incubation mixtures were dialyzed against 0.1 M NaCl followed by water. The radioactive product was either hydrolyzed with 4 and Pro-PhaR1-j cell extracts were compared using a variety of exogenous acceptors and nucleotide sugars ( (Table 3) . When PhaR and wild-type cell extracts were mixed, the total enzyme activity increased to approximately the expected value, indicating that the PhaR cell extract did not inhibit the activity of the wild-type extract.
Both PhaR and wild-type cells were assayed directly for glycosidase activities by incubation of cell extracts with the radioactive glycoprotein products of the transferase (see Ma- terials and Methods) under the conditions of transferase assay. Complete recovery of high-molecular-weight product was observed after incubating either AGP(-SA,Gal,GlcNAc)- Specificity of GlcNAc-T Activity. The GlcNAc-T activity from both PhaR and wild-type CHO cells transferred GlcNAc only to receptors with a terminal a-mannosyl residue (Table 4 ). All four exogenous acceptors used ip this study (Table 2) had terminal a-mannosyl residues.
When either AGP(-SA,Gal,GlcNAc) or RNase B were used as substrates for PhaR or wild-type cell extracts, acid hydrolysis of the reaction products released 75-93% of the radioactivity as free glucosamine, identified by high voltage paper electrophoresis in pyridine acetate pH 3.6. Treatment of these radioactive reaction products with /3-N-acetylglucosaminidase at 370 for 24 hr released 80-87% of the radioactivity as free GlcNAc, identified by descending paper chromatography; radioactive RNase B obtained after incubation with the PhaR cell extract was not analyzed by glycosidase treatment because of technical difficulties associated with the large amount of protein required in the incubation mixture.
The ,B-N-acetylglucosaminidase preparation used in these experiments contained no activity capable .of removing alinked GlcNAc or a-or ,3-linked GalNAc residues. Thus it appears that the reaction catalyzed by GlcNAc-T in both PhaR and wild-type cell extracts is the transfer of a GlcNAc residue in f/-linkage to a terminal a-mannosyl residue.
Independently Selected PhaR Clones. Several independently selected GatrPro+PhaR clones known to bind markedly less 125I-labeled PHA than wild-type cells and to be sensitive to the cytotoxicity of Con A (9) were also found to lack the GlcNAc-T activity (Table 5) It is at present not possible to determine the site of the mutation in these PhaR cells. The absence of the GlcNAc-T activity may be a direct or indirect result of the mutational event. Regardless of the mechanism, presumably the enzyme lesion results in the inability of PhaR cells to attach GlcNAc residues via a certain :-linkage to a-mannosyl termini in the biosynthesis of cellular glycoproteins including those destined for the CHO cell surface. This would in turn lead to an inability to complete the galactosyl (and sialyl) termini of the PHA binding site (11) . Previous studies (11, 12) suggest that the five lectins used here bind to the oligosaccharide portion of the same membrane receptor but at different sites specified partly by their sugar specificities.
Thus, the lack of certain sialyl, l-D-galactosyl and f3-N-acetyl-D-glucosaminyl residues on the PhaR cell surface probably accounts for their resistance to PHA, WGA, LCA, and RIC, for their decreased ability to bind l25-Ilabeled PHA, WGA, LCA, and RIC (unpublished observations), and for the decreased ability of PhaR cells to be labeled with galactose oxidase-tritiated borohydride (10) ; the exposure of mannosyl residues on the PhaR cell surface probably accounts for the increased binding of l25I-labeled Con A and for the increased sensitivity of PhaR cells to the cytotoxicity of Con A. However, an additional PhaR phenotype which possesses full GlcNAc-T activity and a different lectin-resistance phenotype has been described (Table 5) . Further, the interpretation of l25-Ilabeled PHA binding appears to be complex; for example, clones which bind 30-40% as much l25I-labeled PHA as wild-type cells (Gat-Pro+lPhaRl and Gat-Pro+lPhaRlj-) do not possess 30-40% as much GlcNAc-T activity. Thus it would appear that no single criterion is enough to adequately describe the different PhaR phenotypes of CHO cells.
The RIC-resistant CHO cells isolated by Gottlieb et al. (8) have recently been found to exhibit an almost identical decrease in GlcNAc-T activity with IgG(-SA,Gal,GlcNAc) glycopeptide and AGP(-SA,Gal,GlcNAc) (28) . We have now selected resistant CHO cells using RIC, WGA, and LCA and obtained in each case clones possessing the first PhaR phenotype (PhaRConASWgaRRicRLcaR and low levels of GlcNAc-T activity) as well as clones with alternative lectin-resistance phenotypes (Stanley et al., manuscript in preparation). It would appear that a large number of phenotypes may be obtained by these single-step selection techniques, and the glycosyltransferase activities of these mutants are now being investigated. The PhaR CHO cells and other lectin-resistant lines should enable the identity and linkage specificities of many mammalian glycosyltransferases to be described. Also they should provide excellent biological material for studies in cell membrane structure and function.
